KPIs & Operating Metrics(New)
Balance Sheet
Cash Flow Statement
AcquisitionsAmortization of GoodwillCapital ExpendituresCash from Financing ActivitiesCash from Investing ActivitiesCash from OperationsChange in Account PayablesChange in Accured ExpensesChange in Acquisitions & DivestmentsChange in CashChange in InventoryChange in ReceivablesDeferred TaxesDepreciation & Amortization (CF)Dividends Paid - CommonFree Cash FlowGains from Investment SecuritiesLong-Term Debt RepaymentsNet Cash FlowNet IncomeOther Working Capital ChangesOther financing activitiesShare-based CompensationShares IssuedShort-Term Debt issuances
Daily Values
Growth Metrics
Income Statement
Others
Ratios

Cvs Health (CVS) Other financing activities (2016 - 2025)

Cvs Health (CVS) has disclosed Other financing activities for 17 consecutive years, with $7.0 million as the latest value for Q4 2025.

  • For the quarter ending Q4 2025, Other financing activities fell 85.42% year-over-year to $7.0 million, compared with a TTM value of $41.0 million through Sep 2025, up 415.38%, and an annual FY2024 reading of $26.0 million, up 112.94% over the prior year.
  • Other financing activities was $7.0 million for Q4 2025 at Cvs Health, down from $38.0 million in the prior quarter.
  • Across five years, Other financing activities topped out at $75.0 million in Q4 2021 and bottomed at -$149.0 million in Q1 2022.
  • Average Other financing activities over 5 years is -$5.0 million, with a median of $7.5 million recorded in 2023.
  • The sharpest move saw Other financing activities skyrocketed 1575.0% in 2021, then plummeted 833.33% in 2025.
  • Year by year, Other financing activities stood at $75.0 million in 2021, then tumbled by 46.67% to $40.0 million in 2022, then crashed by 77.5% to $9.0 million in 2023, then surged by 433.33% to $48.0 million in 2024, then tumbled by 85.42% to $7.0 million in 2025.
  • Business Quant data shows Other financing activities for CVS at $7.0 million in Q4 2025, $38.0 million in Q3 2025, and -$22.0 million in Q2 2025.